Trade Mind Medicine (MindMed) Inc. Subordinate Voting Shares - MNMD CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.73 |
| Open | 6.8 |
| 1-Year Change | 39.34% |
| Day's Range | 6.74 - 7.14 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 25, 2025 | 6.73 | -0.32 | -4.54% | 7.05 | 7.10 | 6.59 |
| Feb 24, 2025 | 7.13 | -0.47 | -6.18% | 7.60 | 7.60 | 6.95 |
| Feb 21, 2025 | 7.60 | -0.62 | -7.54% | 8.22 | 8.45 | 7.60 |
| Feb 20, 2025 | 8.13 | 0.04 | 0.49% | 8.09 | 8.29 | 7.88 |
| Feb 19, 2025 | 8.22 | -0.06 | -0.72% | 8.28 | 8.45 | 7.80 |
| Feb 18, 2025 | 8.44 | -1.50 | -15.09% | 9.94 | 10.22 | 8.12 |
| Feb 14, 2025 | 9.78 | 0.63 | 6.89% | 9.15 | 10.39 | 9.04 |
| Feb 13, 2025 | 8.63 | -0.09 | -1.03% | 8.72 | 9.02 | 8.16 |
| Feb 12, 2025 | 8.49 | 0.49 | 6.13% | 8.00 | 8.64 | 7.95 |
| Feb 11, 2025 | 8.22 | 0.15 | 1.86% | 8.07 | 8.40 | 7.90 |
| Feb 10, 2025 | 8.17 | 0.02 | 0.25% | 8.15 | 8.54 | 7.81 |
| Feb 7, 2025 | 8.24 | -0.61 | -6.89% | 8.85 | 8.86 | 8.08 |
| Feb 6, 2025 | 8.94 | -0.24 | -2.61% | 9.18 | 9.50 | 8.89 |
| Feb 5, 2025 | 9.32 | 1.21 | 14.92% | 8.11 | 10.14 | 7.84 |
| Feb 4, 2025 | 8.15 | 0.72 | 9.69% | 7.43 | 8.22 | 7.43 |
| Feb 3, 2025 | 7.26 | 0.81 | 12.56% | 6.45 | 7.44 | 6.45 |
| Jan 31, 2025 | 6.75 | -0.34 | -4.80% | 7.09 | 7.28 | 6.75 |
| Jan 30, 2025 | 7.11 | -0.23 | -3.13% | 7.34 | 7.55 | 7.00 |
| Jan 29, 2025 | 7.31 | -0.05 | -0.68% | 7.36 | 7.63 | 7.08 |
| Jan 28, 2025 | 7.42 | 0.13 | 1.78% | 7.29 | 7.47 | 6.88 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Mind Medicine (MindMed) Company profile
Mind Medicine (MindMed) Inc is a biopharmaceutical company that develops clinical-stage psychedelic medicines to treat brain health disorders. The New York-based firm specialises in psychiatry, addiction, pain management and neurology.
Founded in May 2019, MindMed has several drug candidates targeting serotonin, dopamine and acetylcholine systems. These products are based on psychedelic and empathogen substances. The company’s main drug candidate is MM-120, which is a proprietary, pharmaceutically optimised form of LSD. The medication is being developed to treat generalised anxiety disorder (GAD). MindMed is also researching the drug in various dosing regimens for the treatment of attention deficit hyperactivity disorder, also known as attention-deficit/hyperactivity disorder (ADHD), as well as chronic pain.
MM-110, the company’s second advanced drug, is being developed to treat opioid withdrawal. The MM-110, also known by the non-proprietary name zolunicant, is a form of 18-methoxycoronaridine, an ibogaine congener.
The company’s third medicine candidate is MM-402, or R(-)-MDMA, a proprietary form of the R-enantiomer of MDMA (3,4-methylenedioxymethamphetamine). The medicine is being developed for the treatment of core symptoms of autism spectrum disorder.
In addition to its advanced stage drugs, the company also has several earlier stage research programmes through external collaboration, including a multi-year exclusive partnership with University Hospital Basel (UHB) in Switzerland.
MindMed does not own or operate any manufacturing facilities. All clinical and non-clinical materials are supplied by third-party contract manufacturing organisations, or CMOs.
MindMed went public on 27 February 2020 on the Toronto-based NEO Exchange under the ticker ‘MMED’. It is listed on Nasdaq under the symbol ‘MNMD’ and in Germany under the ticker ‘BGHM’.
| Industry: | Biotechnology & Medical Research (NEC) |
One World Trade Center
Suite 8500
NEW YORK
NEW YORK 10007
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com